Evidence Hub

Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response)

J. Anzinger

Emerging Infectious Diseases, 2022

101 citations

Abstract

References 1. Anzinger JJ, Mears CD, Ades AE, Francis K, Phillips Y, Leys YE, et al.; ZIKAction Consortium1,2. Antenatal seroprevalence of Zika and chikungunya viruses, Kingston metropolitan area, Jamaica, 2017–2019. Emerg Infect Dis. 2022;28:473–5. https://doi.org/10.3201/eid2802.211849 2. Freitas ARR, Gérardin P, Kassar L, Donalisio MR. Excess deaths associated with the 2014 chikungunya epidemic in Jamaica. Pathogens and Global Health. 2019;113:27–31. https://doi.org/10.1080/20477724.2019.1574111 3. Evans-Gilbert T. Chikungunya and neonatal immunity: fatal vertically transmitted chikungunya infection. Am J Trop Med Hyg. 2017;96:913–5. https://doi.org/10.4269/ ajtmh.16-0491 4. Sharp TM, Ryff KR, Alvarado L, Shieh W-J, Zaki SR, Margolis HS et al. Surveillance for chikungunya and dengue during the first year of chikungunya virus circulation in Puerto Rico. J Infect Dis. 2016;214(suppl_5):S475–81. https://doi.org/10.1093/infdis/jiw245 5. Freitas ARR, Donalisio MR, Alarcón-Elbal PM. Excess mortality and causes associated with chikungunya, Puerto Rico, 2014–2015. Emerg Infect Dis. 2018;24:2352–5. https://doi.org/10.3201/eid2412.170639

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free